BioVascular, Inc. Expands Executive Team ( SAN DIEGO Feb. 26 /- BioVascular ...)

BioVascular, Inc. Expands Executive Team

Date:2/26/2008

SAN DIEGO, Feb. 26 /PRNewswire/ -- BioVascular, Inc., a company focused on developing novel therapies targeting platelet-mediated diseases, today announced that it appointed Christopher M. Bussineau, Ph.D., to the position of vice president of pharmaceutical operations and Eric Karpinski to the position of vice president, business development and nonvascular operations.

"Dr. Bussineau and Mr. Karpinski each bring skill and experience to BioVascular that will allow us to advance our business objectives," said John Parrish, CEO of BioVascular. "With continuing clinical progress in our two compounds, we will be looking to Mr. Karpinski to advance partnership discussions. Dr. Bussineau will be invaluable for establishing the infrastructure needed for further clinical development and eventual commercialization."

Dr. Bussineau brings relevant experience to BioVascular in the areas of process development as well as clinical and commercial manufacturing. Prior to joining BioVascular, Dr. Bussineau served as vice president and general manager of Cambrex Bio Science Baltimore. Before that, he was senior director of technical operations for the Biopharmaceutical Division of Chiron Corporation, acquired by Novartis in 2006. Dr. Bussineau holds a Ph.D. in chemical engineering from Rice University and a B.A. in chemistry from the University of California, San Diego.

Mr. Karpinski has extensive experience in business development, venture financing and strategic planning in the biopharma industry. He joined BioVascular after six years as a venture capitalist with Forward Ventures where he drove the diligence and supported companies in the portfolio including Hypnion, sold to Eli Lilly for $315M; Novacardia, sold to Merck for $350M; Predix, sold to Epix Medical; and Adiana, sold to Cytyc. Prior to working at Forward Ventures, Mr. Karpinski held business development and strategic planning roles at Genentech, Epix Medical and the pharmaceutical consulting p
'/>"/>

0

GOOD

Page: 1 2
Related biology technology :

1. ATS Medical Expands Open Pivot Heart Valve Offerings
2. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
3. BioLife Solutions Expands Scientific Advisory Board
4. Elekta To Showcase Innovations in Radiotherapy and Unveil New Product That Expands Cancer Treatment Availability
5. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
6. Pharsight Expands Strategic Consulting Services Team
7. Validus Pharmaceuticals Expands Product Portfolio with Acquisition of Bipolar Drug: Equetro(R)
8. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
9. AQUISS Expands Into Significant New Territory
10. NanoBio Expands Drug Development Team for Its Anti-Infective Products
11. BitWine (TM) Nutrition Advisors Network Expands Roster of Licensed Dietitians and Nutritionists

Post Your Comments:

BioVascular, Inc. Expands Executive Team( SAN DIEGO Feb. 26 /- BioVascular ...)